Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma

Francesco d'Amore; John Radford; Mats Jerkeman; Thomas Relander; Herve Tilly; Anders Osterborg; Franck Morschhauser; Martin Gramatzki; Martin Dreyling; Bo Bang; Ole Baadsgaard; Hans Hagberg

Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma

Francesco d'Amore, John Radford, Mats Jerkeman, Thomas Relander, Herve Tilly, Anders Osterborg, Franck Morschhauser, Martin Gramatzki, Martin Dreyling, Bo Bang, Ole Baadsgaard, Hans Hagberg

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Pages (from-to)	999A
Number of pages	1
Journal	Blood
Volume	110
Issue number	11
Publication status	Published - 16 Nov 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{13cb8669070e4d9097e4c8ecf680b4a9,

title = "Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma",

author = "Francesco d'Amore and John Radford and Mats Jerkeman and Thomas Relander and Herve Tilly and Anders Osterborg and Franck Morschhauser and Martin Gramatzki and Martin Dreyling and Bo Bang and Ole Baadsgaard and Hans Hagberg",

year = "2007",

month = nov,

day = "16",

language = "Undefined",

volume = "110",

pages = "999A",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "11",

}

TY - JOUR

T1 - Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma

AU - d'Amore, Francesco

AU - Radford, John

AU - Jerkeman, Mats

AU - Relander, Thomas

AU - Tilly, Herve

AU - Osterborg, Anders

AU - Morschhauser, Franck

AU - Gramatzki, Martin

AU - Dreyling, Martin

AU - Bang, Bo

AU - Baadsgaard, Ole

AU - Hagberg, Hans

PY - 2007/11/16

Y1 - 2007/11/16

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000251100804446&KeyUID=WOS:000251100804446

M3 - Article

SN - 0006-4971

VL - 110

SP - 999A

JO - Blood

JF - Blood

IS - 11

ER -

Zanolimumab (HuMax-CD4 (TM)), a fully human monoclonal antibody: Efficacy and safety in patients with relapsed or treatment-refractory non-cutaneous CD4(+) T-cell lymphoma

UN SDGs

Other files and links

Cite this